Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/AR/Fayetteville
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fayetteville, AR

Studies commonly pay $75 to $4,500 per completed study

131 clinical trials are currently recruiting participants within 30 miles of Fayetteville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

131studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Fayetteville right now

Top 25 of 131 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma (MM) Phase 1 Interventional 258 participants sought
Highlands Oncology Group, PA — Springdale, Arkansas (8.2 mi) · Sponsor: Shanghai Henlius Biotech
See eligibility & contact on ClinicalTrials.gov (NCT07477587)

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck Phase 1 Interventional 1,006 participants sought
Highlands Oncology Group — Fayetteville, Arkansas (0.8 mi) · Sponsor: Seagen, a wholly owned subsidiary of Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT04389632)

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NonSegmental Vitiligo Phase 3 Interventional 180 participants sought
Premier Dermatology Clinical Trials Institute At Northwest Arkansas — Fayetteville, Arkansas (0.8 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06548360)

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Breast Neoplasms Phase 3 Interventional 558 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi) · Sponsor: BioNTech SE
See eligibility & contact on ClinicalTrials.gov (NCT07173751)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Bipolar Disorder Type I With Mania Phase 3 Interventional 450 participants sought
Woodland Research Northwest — Rogers, Arkansas (18.2 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT06929273)

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Melanoma, Non-Small-Cell Lung Cancer Phase 1 Interventional 267 participants sought
Highlands Oncology Group — Fayetteville, Arkansas (0.8 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT05355701)

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD Phase 3 Interventional 284 participants sought
Adverum Clinical Site 198 — Springdale, Arkansas (8.2 mi) · Sponsor: Adverum Biotechnologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07482176)

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

Pneumococcal Immunization, Healthy Volunteers Phase 3 Interventional 2,195 participants sought
Northwest Arkansas Pediatric Clinic- Site Number : 8400039 — Fayetteville, Arkansas (0.8 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT07348692)

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Oligometastatic Prostate Cancer (OMPC) Phase 3 Interventional 450 participants sought
Highlands Oncology Group — Fayetteville, Arkansas (0.8 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05939414)

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Non Small Cell Lung Cancer Phase 3 Interventional 780 participants sought
Highlands Oncology Group-Research Department ( Site 0062) — Springdale, Arkansas (8.2 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06312137)

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

Bipolar I Disorder Phase 2 Interventional 320 participants sought
Pillar Clinical Research — Bentonville, Arkansas (21.0 mi) · Sponsor: LB Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07494305)

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

Atrial Fibrillation N/A Interventional 920 participants sought
Washington Regional Medical Center — Fayetteville, Arkansas (0.8 mi) · Sponsor: Biosense Webster, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07527299)

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Melanoma, Glioma Phase 1 Interventional 124 participants sought
Highlands Oncology Group, PA — Fayetteville, Arkansas (0.8 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT05538130)

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Breast Cancer Phase 3 Interventional 4,220 participants sought
Highlands Oncology Group, PA — Springdale, Arkansas (8.2 mi) · Sponsor: Stemline Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06492616)

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Phase 3 Interventional 304 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06096844)

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Breast Neoplasms, Neoplasm Metastasis Phase 3 Interventional 920 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07174336)

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine Phase 3 Interventional 420 participants sought
Preferred Research Partners - Fayetteville /ID# 270419 — Fayetteville, Arkansas (0.8 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06810505)

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

Platinum-resistant Ovarian Cancer Phase 1 Interventional 100 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi) · Sponsor: Stemline Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07226427)
Google-rated

Top-rated research centers in Fayetteville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Health Initiatives Research

2233 Green Acres Rd, Fayetteville, AR 72703
(479) 575-9600

Clinical Trials Institute of Northwest Arkansas

1651 E Stearns St #110, Fayetteville, AR 72703
(479) 544-3483

UAMS Northwest Regional Campus

★ 3.8
1125 N College Ave, Fayetteville, AR 72703
(479) 713-8000

The Spero Clinic

★ 4.9 (242 reviews)
22 Colt Square Dr, Fayetteville, AR 72703
(479) 333-8422

Woodland Research Northwest

★ 4.3
609 W Dyke Rd, Rogers, AR 72758
(479) 927-3000

Pat Walker Health Center

★ 3.0
525 Garland Ave, Fayetteville, AR 72701
(479) 575-4451
"The ladies at the front desk are very welcoming and friendly. They are very outgoing and were more than happy to help me. I really appreciate the tim…"
— Miller Johnston, 5★

Pillar Clinical Research, Bentonville, Arkansas

★ 4.9
3200 NE Redhawk Dr, Bentonville, AR 72712
(479) 367-2688
"⭐⭐⭐⭐⭐<br><br>I had a great experience with Pillar Clinical Research. The staff was friendly, professional, and made me feel comfortable from the…"
— elexis Thomas, 5★

C & C Market Research

★ 4.1
4201 N Shiloh Dr #1820, Fayetteville, AR 72703
(479) 582-1127
"Tried calling the number says been disconnected ☹️😡"
— Elizabeth Ritcheson (Bettyjo), 1★

Northwest Arkansas Clinical Trials Center, PLLC

★ 5.0
599 S Horsebarn Rd #200, Rogers, AR 72758
(479) 876-8205

Clinical trials in Fayetteville: what's recruiting

The Fayetteville area currently has 131 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fayetteville, the most active research areas are:

  • Cancer & Oncology12 studies
  • Brain & Mental Health3 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Fayetteville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fayetteville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fayetteville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fayetteville pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Fayetteville safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Fayetteville?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fayetteville.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fayetteville typically complete one or two studies per year.

Paid clinical trials near Fayetteville

Other metros within reach

Springfield, MO157 Tulsa, OK172 Little Rock, AR508 Overland Park, KS999 Olathe, KS1,006 Kansas City, MO1,000 Kansas City, KS1,011 Topeka, KS110

More of AR

Little Rock508

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts